Search Results

You are looking at 1 - 10 of 91 items for :

  • "brachytherapy" x
Clear All
Full access

Frederick M. Dirbas

patients with early-stage breast cancer treated with breast conserving therapy . J Surg Oncol 1999 ; 70 : 33 – 40 . 12 King TA Bolton JS Kuske RR . Long-term results of wide-field brachytherapy as the sole method of radiation therapy after

Full access

Thomas J. Pugh, Bao-Ngoc Nguyen, James E. Kanke, Jennifer L. Johnson and Karen E. Hoffman

cells, and brachytherapy, which involves the placement of radioactive material inside the body near the cancer cells. The goal of radiation therapy is to deliver a cancer-sterilizing radiation dose to the treatment target, which may include the prostate

Full access

Benjamin E. Greer, Wui-Jin Koh, Nadeem Abu-Rustum, Michael A. Bookman, Robert E. Bristow, Susana M. Campos, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Patricia J. Eifel, Warner K. Huh, Wainwright Jaggernauth, Daniel S. Kapp, John J. Kavanagh, John R. Lurain III, Mark Morgan, Robert J. Morgan Jr, C. Bethan Powell, Steven W. Remmenga, R. Kevin Reynolds, Angeles Alvarez Secord, William Small Jr and Nelson Teng

: long-term outcome of the randomized PORTEC trial with central pathology review . Int J Radiat Oncol Biol Phys 2005 ; 63 : 834 – 838 . 31 Alektiar KM Venkatraman E Chi DS Barakat RR . Intravaginal brachytherapy alone for intermediate

Full access

Caroline C. Henson, Carmel N. Anandadas, Lisa H. Barraclough, Ric Swindell, Catharine M.L. West and Susan E. Davidson

Rafia, MSc, Universiy of Sheffield, unpublished data). (B) Mean item scores plotted with respect to time after brachytherapy for the rectum/bowel section of Common Terminology Criteria for Adverse Events, version 3, for 368 patients with prostate cancer

Full access

Beryl McCormick

Clin Oncol 2001 ; 19 : 2254 – 2262 . 19 King T Bolton J Kuske R . Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T is, 1, 2 breast cancer . Am J Surg 2000 ; 180

Full access

James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony Victor D’Amico, James A. Eastham, Charles A. Enke, Thomas Farrington, Celestia S. Higano, Eric Mark Horwitz, Philip W. Kantoff, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Gary R. MacVicar, Arnold W. Malcolm, David Miller, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach III, Eric Rohren, Stan Rosenfeld, Sandy Srinivas, Seth A. Strope, Jonathan Tward, Przemyslaw Twardowski, Patrick C. Walsh, Maria Ho and Dorothy A. Shead

traditionally been the main form of treatment. Increasing evidence supports the option of brachytherapy combined with EBRT with or without ADT for this group of patients. On the advanced-disease front, a recent surge in the development of novel agents has

Full access

George Rodrigues, Himu Lukka, Padraig Warde, Michael Brundage, Luis Souhami, Juanita Crook, Fabio Cury, Charles Catton, Gary Mok, Andre-Guy Martin, Eric Vigneault, Jim Morris, Andrew Warner, Sandra Gonzalez Maldonado, Tom Pickles and the Genitourinary Radiation Oncologists of Canada (GUROC)

concomitant use of hormonal therapy. 5 Alternatives to dose-escalated external-beam radiotherapy include low-dose-rate (LDR) 6 and high-dose-rate (HDR) 7 brachytherapy (with or without integrated external-beam radiation therapy), hypofractionated radiation

Full access

Christopher Loiselle and Wui-Jin Koh

concurrent platinum-based chemotherapy and brachytherapy boost has been established as the standard of care in locally advanced disease. In 1999, the publication of 5 randomized trials 3 – 7 led to the February 1999 NCI recommendation to consider

Full access

Miren Gaztañaga and Juanita Crook

less supporting evidence. It may be prescribed as primary treatment in nonmetastatic disease, especially in elderly patients, or in conjunction with brachytherapy. As prostate cancer is the most common cancer in men in the developed world, this wide

Full access

Heidi J. Gray

Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix . Int J Radiat Oncol Biol Phys 2000 ; 48 : 201 – 211 . 18. Nag S Orton C Young D Erickson B . The American brachytherapy society survey of